Intrapulmonary concentrations of ceftobiprole high doses administered by continuous infusion in critically ill patients with community-acquired pneumonia
The use of high doses of ceftobiprole given by CI may be necessary to achieve PK/pharmacodynamic targets in ELF in critically ill patients with CAP and normal renal function, especially when less susceptible pathogen is suspected or identified.
Authors
- Claire Roger (ORCID: https://orcid.org/0000-0002-6055-0034)
- Dominique Breilh (ORCID: https://orcid.org/0000-0002-3783-2797)
- Bernard Allaouchiche (ORCID: https://orcid.org/0000-0003-0988-1716)
- Bob‐Valéry Occéan (ORCID: https://orcid.org/0000-0003-4335-7862)
- Arnaud Friggeri (ORCID: https://orcid.org/0000-0003-4687-2173)
- Diana de Freitas Serapiao Moraes
- Laurent Müller (ORCID: https://orcid.org/0000-0002-8788-179X)
- Jean Yves Lefrant
- Olivier Ulrich Feudjio
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Université de Bordeaux (FR)
- Université de Montpellier (FR)
- Centre Hospitalier Universitaire de Bordeaux (FR)
- Centre Hospitalier Universitaire de Montpellier (FR)
- VetAgro Sup (FR)
- Bordeaux Population Health (FR)
- Hôpital Lyon Sud (FR)
- Adlink (United Kingdom) (GB)
- Université de Nîmes (FR)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1093/jac/dkaf267
- Citations
- 1
- Primary Topic
- Antibiotics Pharmacokinetics and Efficacy
- Type
- article
- Field-Weighted Citation Impact
- 1.39